The Cyprus capital market continues to grow despite tougher conditions, and with it, the regulator is expanding to cope with the additional burden.

A survey on the likelihood of young people getting addicted to social media and the internet has shown that 8.3% of Cypriot youth is faced with symptoms of addiction to social media, while the replies of 24% of participants suggested an overall problematic use of the internet.

The government in the Republic of Cyprus has approved access to home test kits for Covid-19, but the use of an antigen non-invasive test using saliva is not on the approved list per health ministry policy.

The Interim Solution providing for the establishment of an ultimate beneficial ownership (UBO) Register for Cypriot entities has launched on 16 March 2021 and is in operation. The obligation to identify and record all relevant information of the beneficial owner(s) who own or control entities burdens all Cypriot entities, including companies incorporated or registered under the Companies Act (Cap.113) and European public limited liability companies. Moreover, the Registrar of Companies has also announced that the final solution will be established following the conclusion of this Interim Solution and the collection of all UBO information.

EY Cyprus is proud to announce the launch of a new Web-Based Learning (WBL) initiative, an expansion of the offerings of the EY Academy of Learning and Development.

Job vacancies in Cyprus recorded an annual increase by 6.8% in the 4th quarter of 2020, with the largest increases being recorded in Manufacturing and Information and Communication sectors.

It has been decided to buy an amount of the Russian Sputnik V vaccine once it will be approved by the European Medicines Agency, government spokesman Kyriakos Koushos told state radio.

The island’s Pharmaceutical Service has set up a call centre for citizens who need to report possible post-vaccination side effects or are desperate for guidance or advice.

Pharmacists’ long-standing wish to contribute to the island’s rapid test efforts has received the Health Ministry’s nod, the head of the Pancyprian Pharmaceutical Association Eleni Piera-Isseyegh told Kathimerini Cyprus.

The European Commission has launched the process for a vote in the Quality Committee on March 26 on the Protected Designation of Origin (PDO) of the Halloumi/Hellim file, an EC spokesperson told the Cyprus News Agency (CNA) on Tuesday.